Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
300
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Libman-Sacks Disease
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
59
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Mouth Neoplasms
|
group |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
140
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Monocyte count procedure
|
phenotype |
|
Laboratory Procedure
|
139
|
296
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Blood basophil count (lab test)
|
phenotype |
|
Laboratory Procedure
|
272
|
452
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Monocyte count result
|
phenotype |
|
Laboratory or Test Result
|
139
|
296
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Psoriasis vulgaris
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
255
|
80
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Lymphocyte Count measurement
|
phenotype |
|
Laboratory Procedure
|
338
|
456
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Granulocyte count
|
phenotype |
|
Laboratory Procedure
|
100
|
150
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Cholangitis, Sclerosing
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
188
|
276
|
0.100 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
Adverse effects, not elsewhere classified
|
disease |
|
Injury or Poisoning
|
55
|
54
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Neutrophil count (procedure)
|
phenotype |
|
Laboratory Procedure
|
145
|
234
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Glaucoma
|
disease |
Eye Diseases
|
Disease or Syndrome
|
770
|
198
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Immune System Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
451
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Platelet Count measurement
|
phenotype |
|
Laboratory Procedure
|
265
|
457
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Endometrioma
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
279
|
4
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Gastric Adenocarcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
453
|
235
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Adult Angiosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
101
|
1
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cervix carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1881
|
283
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Age related macular degeneration
|
disease |
Eye Diseases
|
Disease or Syndrome
|
685
|
663
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Proliferative vitreoretinopathy
|
disease |
Eye Diseases
|
Disease or Syndrome
|
142
|
14
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Lung Diseases, Interstitial
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
319
|
144
|
0.010 |
None |
1.000 |
1 |
1
|
2017 |
2017 |